MONTVALE, N.J., Nov. 2 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals
Corp. (Nasdaq: MEMY) announced today that it will report its Third quarter
2006 financial results on Thursday, November 9, 2006, before the U.S.
financial markets open. Management will provide a Company update and discuss
the third quarter results during a conference call on Thursday, November 9,
2006, at 9:00 a.m. EST.
Investors and other interested parties may access the call as follows:
Date: Thursday, November 9, 2006
Time: 9:00 a.m. EST
Telephone (U.S.): 800.299.9086
Telephone (international): 617.786.2903
Participant Passcode: 87308676
Webcast: http://www.memorypharma.com under the
"Investors" section
An audio replay of the conference call will be available from 11:00 a.m.
EST on Thursday, November 9, 2006, until Thursday, November 16, 2006. To
access the replay, please dial 888.286.8010 (U.S.) or 617.801.6888
(international) and enter pass code number 44660408. An audio replay of the
conference call will also be available under the "Investors" section of the
Company's website during the same period.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on
developing innovative drugs for the treatment of debilitating CNS disorders
such as Alzheimer's disease, schizophrenia, depression and bipolar disorder.
For additional information, please visit our website at
http://www.memorypharma.com.
SOURCE Memory Pharmaceuticals Corp.
-0- 11/02/2006
/CONTACT: Jzaneen Lalani of Memory Pharmaceuticals Corp., Vice President,
Legal Affairs, +1-201-802-7249, or Laura Perry of Stern Investor Relations,
Inc., +1-212-362-1200/
/Web site: http://www.memorypharma.com/
(MEMY)
CO: Memory Pharmaceuticals Corp.
ST: New Jersey
IN: HEA BIO MTC
SU: CCA
KP
-- NYTH043 --
4811 11/02/2006 09:16 EST http://www.prnewswire.com
